Related references
Note: Only part of the references are listed.In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process
Yao Zhang et al.
PROTEIN EXPRESSION AND PURIFICATION (2021)
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
Basmah N. Aldosari et al.
PHARMACEUTICS (2021)
Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
Ivars Petrovskis et al.
MICROORGANISMS (2021)
Process development for cross-flow diafiltration-based VLP disassembly: A novel high-throughput screening approach
Nils Hillebrandt et al.
BIOTECHNOLOGY AND BIOENGINEERING (2021)
Lipid nanoparticles for mRNA delivery
Xucheng Hou et al.
NATURE REVIEWS MATERIALS (2021)
Integrated Process for Capture and Purification of Virus-Like Particles: Enhancing Process Performance by Cross-Flow Filtration
Nils Hillebrandt et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Process monitoring of virus-like particle reassembly by diafiltration with UV/Vis spectroscopy and light scattering
Matthias Ruedt et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Membrane-Based Approach for the Downstream Processing of Influenza Virus-Like Particles
Sofia B. Carvalho et al.
BIOTECHNOLOGY JOURNAL (2019)
Current RNA-based Therapeutics in Clinical Trials
Ling-Yan Zhou et al.
CURRENT GENE THERAPY (2019)
Journey of siRNA: Clinical Developments and Targeted Delivery
Rahul R. Nikam et al.
NUCLEIC ACID THERAPEUTICS (2018)
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
Jayesh A. Kulkarni et al.
NUCLEIC ACID THERAPEUTICS (2018)
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Norbert Pardi et al.
NATURE COMMUNICATIONS (2018)
mRNA therapeutics deliver a hopeful message
Zifu Zhong et al.
NANO TODAY (2018)
Yield Optimisation of Hepatitis B Virus Core Particles in E-coli Expression System for Drug Delivery Applications
Izzat Fahimuddin Bin Mohamed Suffian et al.
SCIENTIFIC REPORTS (2017)
Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery
Marcus J. Rohovie et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2017)
The Structural Biology of Hepatitis B Virus: Form and Function
Balasubramanian Venkatakrishnan et al.
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
Christopher Ladd Effio et al.
BIOTECHNOLOGY JOURNAL (2015)
Lipid-Based Nanocarriers for RNA Delivery
Hui Yi Xue et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications
Arnis Strods et al.
SCIENTIFIC REPORTS (2015)
Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
Christopher Ladd Effio et al.
BIOTECHNOLOGY JOURNAL (2015)
Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer
Jinming Li et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells
Alejandro Negrete et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Native agarose gel electrophoresis and electroelution: A fast and cost-effective method to separate the small and large hepatitis B capsids
Kam Yee Yoon et al.
ELECTROPHORESIS (2013)
Systemic Delivery of siRNA by Chimeric Capsid Protein: Tumor Targeting and RNAi Activity in Vivo
Kyung-mi Choi et al.
MOLECULAR PHARMACEUTICS (2013)
A VLP Library of C-Terminally Truncated Hepatitis B Core Proteins: Correlation of RNA Encapsidation with a Th1/Th2 Switch in the Immune Responses of Mice
Irina Sominskaya et al.
PLOS ONE (2013)
Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles
Qinjian Zhao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Current progress of siRNA/shRNA therapeutics in clinical trials
John C. Burnett et al.
BIOTECHNOLOGY JOURNAL (2011)
Potential clinical applications of siRNA technique: benefits and limitations
Shao-Hua Chen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance
J. Zachary Porterfield et al.
VIROLOGY (2010)
Structural comparisons of hepatitis B core antigen particles with different C-terminal lengths
Shuyu Liu et al.
VIRUS RESEARCH (2010)
Solid lipid nanoparticles for targeted brain drug delivery
Paolo Blasi et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)
Henryk Mach et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells
A Cooper et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Hepatitis B virus core antigen:: Enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen
WS Tan et al.
BIOLOGICAL CHEMISTRY (2003)
Share Paper
